The Institute for Clinical and Economic Review (ICER) today released an Evidence Report assessing the comparative clinical effectiveness and value of three digital health technologies that have been developed to treat opioid use disorder (OUD):
- reSET-O® (Pear Therapeutics), a 12-week prescription digital app, used in conjunction with buprenorphine and small rewards, aimed at increasing retention of patients receiving outpatient OUD treatment
- Connections (Chess Health), a digital app that combines communication with addiction experts and support groups, along with a 7-session program that teaches cognitive and behavioral skills, aimed at improving abstinence in patients with substance use disorders
- DynamiCare (DynamiCare Health), a digital app that includes 36 classroom-based training modules, monitoring for substance abstinence, and debit card rewards for negative drug tests and appointment attendance
“While the opioid epidemic continues to ravage American communities, ICER remains committed to providing independent evaluations of the relevant clinical evidence – as we have done for abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, non-drug interventions for lower back pain, and supervised injection facilities,” said Pamela Bradt, MD, MPH, ICER’s Chief Scientific Officer. Find out more here.